Home » Topics » Regulatory » Patents

Patents
RSS

Novel P2X3 receptor antagonists claimed by Merck & Co. as analgesics

May 28, 2009

Orchid Chemicals & Pharmaceuticals describes novel HDAC inhibitors as oncolytic compounds

May 28, 2009

Abbott presents 5-HT6 receptor ligands for the treatment of cognitive dysfunctions

May 27, 2009

Bristol-Myers Squibb discloses androgen receptor antagonists for the treatment of cancer

May 27, 2009

Merck KGaA prepares and tests novel 11beta-HSD1 inhibitors

May 27, 2009

Allergan claims prostanoid EP2 receptor agonists for the treatment of glaucoma

May 27, 2009

Sanofi-aventis presents novel histamine H3 receptor modulators for sleep disorders

May 27, 2009

Janssen claims novel PARP-1 inhibitors for cancer treatment

May 26, 2009

Sanofi-aventis discovers novel vanilloid TRPV1 receptor antagonists for the treatment of pain

May 26, 2009

Daiichi Sankyo claims novel antidiabetic compounds

May 26, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...